Clinical Management of Canine Vaginal Hyperplasia: Decision-Making From Presentation to Resolution

Canine vaginal hyperplasia is a hormonally driven condition that can range from mild mucosal eversion to severe protrusion requiring urgent intervention. While the condition is often self-limiting, clinical management depends heavily on presentation, tissue condition, and associated complications. A structured approach is therefore essential to ensure optimal outcomes while avoiding unnecessary surgical intervention. 

Clinical Presentation and Emergency Considerations 

Vaginal hyperplasia becomes clinically significant when protruded tissue is exposed beyond the vulvar rim, particularly in Type II and Type III presentations. Although many cases present with viable and non-ulcerated mucosa, the condition must be considered an emergency when the exposed tissue becomes dry, traumatized, or necrotic, or when urination is impaired due to urethral involvement¹. 

In the observed cases, most tissues were in good condition without necrosis or ulceration; however, one case required urinary catheterization due to involvement of the urethral meatus. Similar complications have been described, including severe cases where even bladder involvement makes catheterization difficult1. These findings highlight the importance of early evaluation and timely intervention. 

Initial Assessment and Clinical Approach¹ 

The initial assessment focuses on determining the severity of protrusion, tissue viability, and urinary function. The classification into Type I, II, or III plays a critical role in guiding treatment decisions. Additionally, clinicians must consider the stage of the estrous cycle, as vaginal hyperplasia typically occurs during the follicular phase when estrogen levels are elevated. 

In many cases, especially when tissues remain healthy, conservative management is justified. This includes protecting the exposed mucosa from trauma and monitoring the progression of the estrous cycle. The natural hormonal shift toward diestrus, characterized by decreased estrogen and increased progesterone, leads to reduction of edema and spontaneous resolution of the condition. 

Conservative Management Strategies 

Several authors describe conservative treatment approaches that include cleaning, hydration, and protection of the prolapsed tissues, with or without pharmacological induction of ovulation. The rationale behind inducing ovulation is to shorten the estrogen-dominant phase and reduce the risk of further protrusion during the same cycle^1,2. 

However, not all clinicians opt for hormonal manipulation. In the cases discussed, the authors chose to monitor the animals without pharmacological intervention, relying instead on the physiological progression of the estrous cycle. This approach proved effective, as resolution occurred with the onset of diestrus. 

Surgical Intervention and Indications¹ 

Surgical intervention is reserved for cases where conservative management is insufficient or when complications such as ulceration and necrosis are present. Amputation of the prolapsed tissue is one of the described surgical options, particularly in severe or complicated cases¹. 

Nevertheless, when tissues are viable, less invasive procedures such as repositioning and vulvar suturing are preferred. This approach minimizes tissue damage while effectively preventing recurrence during the same estrous cycle. Literature supports this method, with several reports describing successful outcomes using vulvar repositioning and suturing techniques. 

Monitoring and Follow-Up¹ 

Post-treatment monitoring is essential to ensure resolution and detect any recurrence. In some cases, mild hyperplasia may persist temporarily due to prolonged estrogen exposure, but progression to severe prolapse can be prevented with appropriate management. Monitoring the estrous cycle through vaginal cytology or hormonal assessment helps guide clinical decisions and timing of interventions. 

Recurrence and Long-Term Management¹ 

Recurrence is a well-documented feature of vaginal hyperplasia, particularly in predisposed breeds and individuals. For animals not intended for breeding, ovariectomy or ovariohysterectomy is recommended as a definitive solution, as it eliminates hormonal cycling and prevents recurrence. 

Conclusion 

The management of canine vaginal hyperplasia requires a balanced and case-specific approach. While conservative strategies are effective in many cases, clinicians must remain vigilant for complications that necessitate surgical intervention. Understanding the hormonal basis of the condition and its clinical progression allows for informed decision-making and improved patient outcomes. 

References: 

1. Bucci R, Fusi J, Robbe D, Veronesi MC, Carluccio A. Management of vaginal hyperplasia in bitches by Bühner suture. Animals. 2022 Dec 12;12(24):3505. https://doi.org/10.3390/ani12243505 
2. Ahuja AK, Shivkumar S, Singh AK, Dhindsa SS. Management of true vaginal prolapse in bitch. International Journal of Environment, Agriculture and Biotechnology. 2017;2(4):238837. https://www.academia.edu/download/53952885/25_Management_of_True_Vaginal_Prolapse.pdf